Ocean Biomedical, Inc.
OCEA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $1 | $1 |
| Operating Income | -$1 | $2 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$7 | $4 | -$5 | -$17 |
| Pre-Tax Income | -$8 | $6 | -$6 | -$17 |
| Tax Expense | $0 | -$3 | $0 | $0 |
| Net Income | -$8 | $0 | -$6 | -$17 |
| % Margin | – | – | – | – |
| EPS | -0.3 | 0.01 | -0.2 | -0.63 |
| % Growth | -3,100% | 105% | 68.3% | – |
| EPS Diluted | -0.3 | 0.01 | -0.2 | -0.63 |
| Weighted Avg Shares Out | 28 | 28 | 27 | 27 |
| Weighted Avg Shares Out Dil | 28 | 28 | 27 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | $1 | -$5 | -$17 |
| % Margin | – | – | – | – |